email article
Hospitalized COVID-19 patients treated with high-titer convalescent plasma showed no survival benefits or clinical improvements compared to patients only receiving usual care, according to data from the U.K. s RECOVERY trial.
Both groups had a mortality rate of 24% at 28 days (RR 1.00 95% CI 0.93-1.07,
P=0.95), reported Peter Horby, PhD, of the University of Oxford in England, and colleagues.
There was also no difference between groups in hospital stay duration or chance of disease progression, the authors wrote in This study is significant since the Recovery Collaborative Group organized the largest randomized trial in reporting COVID-19 convalescent therapy mortality results, Horby and colleagues wrote.
sudok1 / iStock
Convalescent plasma given to hospitalized COVID-19 patients did not improve survival or rates of release from the hospital within 28 days, need for invasive mechanical ventilation, or death, according to the most recent findings of the Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial in the United Kingdom.
The results, published late last week in
The Lancet, add to evidence that SARS-CoV-2 antibody-rich plasma taken from COVID-19 survivors doesn t benefit severely ill coronavirus patients. The RECOVERY trial is evaluating several possible treatments for hospitalized COVID-19 patients at 177 National Health Services sites.
Death, mechanical ventilation, hospital release
The researchers assigned 11,558 patients to receive either convalescent plasma or usual care in a 1:1 ratio from May 28, 2020, to Jan 15, 2021.
Crain s Content Studio: Empire Anthem | Crain s New York Business
The Covid-19 pandemic has brought extraordinary challenges to all New Yorkers. Families have grappled with the devastating impact of the virus, and businesses and workers have faced financial distress. In many respects, the crisis has brought out the best in New Yorkers as they step up to make a difference whether in a hospital intensive care unit serving patients, in a restaurant kitchen making meals for front-line workers and the elderly, or in a research laboratory seeking vaccines and treatments to battle Covid-19.
Today, Empire BlueCross BlueShield is honored to recognize 50 Whole Health Heroes who unflinchingly have fought against the unseen enemy, often sacrificing their own health and personal comfort to help others. These New Yorkers, who hail from the health care sector, the business world and the nonprofit field, have displayed extraordinary leadership, dedication, empathy, and remarkable compassion to he